The Side Effects of Zyprexa May Be Deadly

Kahn Gauthier Swick is investigating possible legal actions against Eli Lilly and Company, the manufacturer of the prescription drug Zyprexa (olanzapine), on behalf of patients prescribed Zyprexa who have developed side effects such as diabetes, hyperglycemia (elevated blood sugar), and other blood sugar disorders as a result of being on Zyprexa.

In April 2002 the Japanese Ministry of Health, Labour and Welfare Ministry warned Eli Lilly Japan concerning side effects of Zyprexa after the deaths of two diabetic users of the drug. The ministry said seven other Zyprexa patients had lost consciousness or become comatose after taking Zyprexa in the previous 10 months. The ministry said no new diabetes patients should be treated with Zyprexa and ordered Eli Lilly to warn doctors to closely monitor diabetics already on the Zyprexa medication.

A study published in the July 2, 2002, issue of Pharmacotherapy found 289 cases of diabetes in patients who had been prescribed Zyprexa. Of the 289 cases, 225 were newly diagnosed cases. One hundred patients developed Zyprexa side effects such as ketosis (presence in the bloodstream of chemicals that the body makes when there is not enough insulin and it must break down fat for its energy), and 22 people developed pancreatitis (inflammation of the pancreas), which is a life-threatening condition. There were 23 deaths due to Zyprexa, including a 15-year-old adolescent who died of necrotizing pancreatitis, a condition where the pancreas breaks down and dies. Most cases (71 percent) occurred within six months of starting the drug and many cases were associated with moderate weight gain.

If side effects of Zyprexa have harmed you , register and contact us today.